Вы искали: virkningsendepunkt (Датский - Английский)

virkningsendepunkt
efficacy endpoint

det primære virkningsendepunkt var antal aspirerede oocytter.
the primary efficacy endpoint was number of oocytes retrieved.

det primære virkningsendepunkt var frekvensen af levedygtige graviditeter.
the primary efficacy endpoint was vital pregnancy rate.

antal aspirerede oocytter var et centralt sekundært virkningsendepunkt.
the number of oocytes retrieved was a key secondary efficacy endpoint.

centralt sekundært virkningsendepunkt (cv-død/mi/ apopleksi) §
key secondary efficacy endpoint (cv death / mi / stroke) §

det primære virkningsendepunkt var samlet overlevelse (overall survival, os).
the primary efficacy endpoint was overall survival (os).

det primære virkningsendepunkt i studie mcl-002 var progressionsfri overlevelse (pfs).
the primary efficacy endpoint in study mcl-002 was progression-free survival (pfs).

studiet opfyldte det primære virkningsendepunkt for begge de anvendte doser pasireotid til intramuskulær anvendelse.
the study met its primary efficacy endpoint for both pasireotide intramuscular use doses.

det primære virkningsendepunkt var forekomst af verificeret/sandsynlig ifi 16 uger efter randomisering bestemt af et uafhængigt, blindet eksternt ekspertpanel.
the primary efficacy endpoint was the incidence of proven/probable ifis at 16 weeks post-randomization as determined by an independent, blinded external expert panel.

et sekundært virkningsendepunkt var ændring i visus ved uge 24 sammenlignet med baseline, som var statistisk signifikant til fordel for eylea i vibrant-studiet.
a secondary efficacy endpoint was change in visual acuity at week 24 compared to baseline, which was statistically significant in favour of eylea in the vibrant study.

det primære virkningsendepunkt var forekomst af verificeret/sandsynlig ifi bestemt af et uafhængigt, blindet eksternt ekspertpanel i on-treatment perioden.
the primary efficacy endpoint was the incidence of proven/probable ifis as determined by an independent, blinded external expert panel during the on-treatment period.

tabel 4: primært og centralt sekundært virkningsendepunkt hos post-mi- og pad-patienter uden apopleksi eller tci i anamnesen
table 4: primary and key secondary efficacy endpoints in post-mi or pad patients with no history of stroke or tia

den gennemsnitlige absolutte ændring fra baseline til og med uge 24 i procent forventet fev1 (primært virkningsendepunkt) var 2,57 procentpoint i ivacaftorgruppen og 0,46 procentpoint i placebogruppen.
the mean absolute change from baseline through week 24 in percent predicted fev1 (primary efficacy endpoint) was 2.57 percentage points in the ivacaftor group and 0.46 percentage points in the placebo group.

i en kombineret dataanalyse af galileo og copernicus viste eylea klinisk relevante ændringer fra baseline i det forudspecificerede sekundære virkningsendepunkt i national eye institute visual function questionnaire (nei vfq-25).
in combined data analysis of galileo and copernicus, eylea demonstrated clinically meaningful changes from baseline in pre-specified secondary efficacy endpoint national eye institute visual function questionnaire (nei vfq-25).

i begge disse undersøgelser var tenofovirdisoproxilfumarat signifikant bedre end adefovirdipivoxil med hensyn til det primære virkningsendepunkt, som var komplet respons (defineret som hbv- dna- niveauer < 400 kopier/ ml og en forbedring af knodell' s nekroinflammatoriske score på mindst 2 points uden forværring af knodell' s fibrosescore).
in both of these studies tenofovir disoproxil fumarate was significantly superior to adefovir dipivoxil for the primary efficacy endpoint of complete response (defined as hbv dna levels < 400 copies/ ml and knodell necroinflammatory score improvement of at least 2 points without worsening in knodell fibrosis).